Scientist found to have falsified data in thesis sues to keep her PhD

In August 2012, the authors of “Novel Approach to the Lundurine Alkaloids: Synthesis of the Tetracyclic Core,” a paper in Organic Letters, retracted it: The authors retract this Organic Letters communication on the basis that the RCM of 24 to give 25 (Scheme 6) is not reproducible; thus, the reduction of 25 to give 26 … Continue reading Scientist found to have falsified data in thesis sues to keep her PhD

Does publicly questioning papers lead to more corrections and retractions?

As Retraction Watch readers will likely recall, Paul Brookes ran Science-Fraud.org anonymously until early 2013, when he was outed and faced legal threats that forced him to shut down the site. There are a lot of lessons to be drawn from the experience, some of which Brookes discussed with Science last month. Today, PeerJ published Brookes’ … Continue reading Does publicly questioning papers lead to more corrections and retractions?

Weekend reads: Impact factor mania, male scientists citing themselves, insecure careers in academia

Another busy week at Retraction Watch, which we kicked off by asking for your support. Have you contributed yet? Here’s what was happening elsewhere on the web:

Weekend reads: STAP stem cell controversy grinds on, plagiarism puzzles

Another busy week here at Retraction Watch, with many in the scientific world glued to their browsers for more information on the latest stem cell controversy. Hear Ivan on the BBC discussing what that story means for post-publication peer review. Elsewhere around the web:

So what happened after Paul Brookes was forced to shut down Science-Fraud.org?

Retraction Watch readers will likely be familiar with the story of Paul Brookes, the University of Rochester researcher whose identity as the person behind Science-Fraud.org was revealed in January 2013. That revelation — and legal threats — forced Brookes to shutter Science-Fraud.org. In a new illuminating interview in Science, Brookes discusses the legal threats he … Continue reading So what happened after Paul Brookes was forced to shut down Science-Fraud.org?

Not-so-tiny ethics issues as Micron retracts first-ever paper, and authors apologize for five duplicates

The editors of the journal Micron — an Elsevier title — have retracted its first paper ever, and in an editorial marking the occasion, take on a number of issues in scientific publishing misconduct. The beginning of the editorial (which is paywalled):

Co-author of controversial acid STAP stem cell papers in Nature requests retraction: report

A co-author of two papers claiming to have shown how to create stem cells simply and easily has requested their retraction, the Wall Street Journal is reporting:

Should readers get a refund when they pay to access seriously flawed papers?

Time for another installment of Ask Retraction Watch: Let’s say I’m collecting relevant papers to write a review, or preparing a project, and I have rather limited time. I find a few interesting papers, bump into some paywalls, ask the authors for the .pdf without any response, and finally I decide to pay, say, $20 … Continue reading Should readers get a refund when they pay to access seriously flawed papers?

Figure duplication kills cell death paper

A pair of researchers at the University of Maryland have retracted a paper in Cell Death & Differentiation after it became clear that one of the figures had been duplicated from an earlier paper. Here’s the notice, dated December 13, 2013, for “INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis,” by Suryakant Niture and … Continue reading Figure duplication kills cell death paper

Herbicide-ovarian cancer study to be retracted

The authors of a 2008 study purporting to explain how the herbicide atrazine acts on cancer cells have asked the journal that published it to retract it for “inadvertent errors,” Retraction Watch has learned. The notice for “G-Protein-Coupled Receptor 30 and Estrogen Receptor-a are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer … Continue reading Herbicide-ovarian cancer study to be retracted